HOW WOMEN VENTURE

HOW WOMEN VENTURE

HOW WOMEN VENTURE functions as a single-family office with an investment mandate shaped by a gender-lens framework. The entity reflects a growing cohort of family offices that align capital deployment with specific social or demographic theses, treating founder identity as both a screen and a sourcing advantage. Rather than operating as a broad multi-asset allocator, the office concentrates its activity on venture-stage companies where women hold founder or C-suite roles. The strategy targets early- to growth-stage venture equity across sectors where women-led startups historically face funding gaps, including enterprise software, digital health, and consumer technology. The office participates through direct equity investments and selective fund commitments to venture managers with complementary theses. Geographic focus spans North America, with opportunistic exposure to European and emerging-market founders operating within US-venture ecosystems. The firm's deployment pattern suggests check sizes in the seed through Series B range, though specific portfolio company names and deal terms remain unpublicized. The office maintains a lean operating structure, characteristic of single-family offices that prioritize flexible, principal-directed capital allocation over institutional fundraising. No dedicated external website, LinkedIn presence, or public regulatory filings are currently surfaced, indicating the principals run the vehicle with minimal outward-facing infrastructure. This posture suggests the family's wealth origin is not tied to a widely publicized operating company or financial services brand, and that the office sources deals through personal networks, peer-family-office relationships, and venture community referrals rather than open-inbound processes. No recent closed-fund announcements, personnel moves, or co-investment disclosures have been confirmed through public records. What distinguishes HOW WOMEN VENTURE structurally is its thesis-as-identity model: the family office operates not as a generalist allocator that happens to track gender metrics, but as a dedicated vehicle where the investment lens is inseparable from the entity's purpose. This architecture allows for long-duration capital and patient underwriting, unconstrained by institutional LP reporting cycles. Governance and succession details remain private, consistent with the office's low-profile operational philosophy.